Actuate Therapeutics (ACTU) Q1 2025 Earnings

Mar 13Confirmed
Q4 2024
Q1 2025
-0.55
-0.46
-0.38
-0.29

Details

Expected EPS
-0.29
Actual EPS
-0.33
Surprise EPS
-0.04
Surprise Percent
-13.79%

Description

⁨Actuate Therapeutics⁩ (⁦ACTU⁩) has reported earnings of ⁦-0.33⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts